GlassScriptPhysician profile
Edith Gracius-Green
NPI 1174368310
$854.51
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $676 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $239.68 | 2024 | Airsupra |
| Axsome Therapeutics, INC. | $124.91 | 2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $121.35 | 2024-2025 | Rexulti |
| Amgen INC. | $113.75 | 2024 | Repatha |
| Neurocrine Biosciences, INC. | $94.68 | 2024 | Ingrezza |
| Vertex Pharmaceuticals Incorporated | $43.05 | 2025 | |
| Abbvie INC. | $31.74 | 2025 | |
| Novo Nordisk INC | $30.75 | 2025 | |
| Kyowa Kirin, INC. | $23.37 | 2025 | |
| Glaxosmithkline, LLC. | $16.35 | 2025 | Bexsero, Penmenvy |
| Alkermes, INC. | $14.88 | 2025 | Aristada, Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Gracius-Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.